NEC Corporation

NIPNF | OTC

Price Alert Chart Builder DCF Calculator

$32.00

-$0.10 (-0.31%)

At close: Oct 9, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

-0.31%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Oct 10, 2026

42.9

+1.4 pts

Fundamentals Average

Market Sentiment Neutral

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $42.44B

1D Range

32.00 32.10

52W Range

21.65 41.00

Valuation (TTM)

PE 21.84

PB 3.09

EV/EBITDA 11.73

Valuation (NTM)

Forward PE 21.88

Forward PEG 0.96

Price Target N/A

Cash Flow

FCF Yield 4.0%

SBC Adj. FCF Yield 4.0%

SBC Impact N/A

Margins

Gross Margin 33.5%

Operating Margin 11.2%

FCF Margin 7.2%

Growth (CAGR)

Revenue 3Y | 5Y 3.1% | 3.8%

Dil EPS 3Y | 5Y -20.6% | -16.9%

FCF 3Y | 5Y 41.7% | 7.8%

Returns

ROA 6.7%

ROE 14.2%

ROIC 9.4%

Financial Health

Net Debt

¥21.89B ($134.68M)

Current Ratio 1.34

Interest Coverage 22.08

Dividends

Div Yield 0.78%

Payout Ratio 0.1%

FCF Payout Ratio 19.0%

All Key Statistics

Loading financial charts...

Profile

NEC Corporation provides information technology services and social infrastructure in Japan and internationally. The company offers systems integration services, including system construction and cons...

Sector Technology

Industry Information Technology Services

Employees 101,800

IPO Date Jul 15, 2020

Website www.nec.com

Fiscal Year April - March

Full Company Profile

Latest News

1 month ago · businesswire.com

NEC Announces Ohio Attorney General's Office Upgrade to Integra-ID® 7 Software-as-a-Service Biometric Platform

FOLSOM, Calif.--(BUSINESS WIRE)--NEC Corporation today announced that the Ohio Attorney General's Office (AGO), through the Ohio Bureau of Criminal Investigation (BCI), is upgrading its biometric identification system to NEC's next-generation Integra-ID® 7 Software-as-a-Service (SaaS) platform, hosted within the Microsoft Azure Government Cloud environment.The large-scale modernization project transitions the State of Ohio's existing on-premises Integra-ID MBIS environment to a fully managed Saa.

3 months ago · businesswire.com

First Bellwether Trial Today Against Reckitt Benckiser's Mead Johnson in NEC Baby Formula MDL Led by Levin Papantonio

PENSACOLA, Fla.--(BUSINESS WIRE)--Reckitt Benckiser (LON: RKT) subsidiary, Mead Johnson is facing the first bellwether today as part of a multidistrict litigation (MDL) in the US District Court for the Northern District of Illinois over its infant formula Enfamil being linked to necrotizing enterocolitis (NEC) in a premature infant. Inman v. Mead Johnson & Company, LLC, et al. is the first case against Mead Johnson in the MDL to proceed to trial. NEC is a severe intestinal disease that can.